-
Macroeconomic Analysis
NewNorway PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing, and utilities contributed 41.7% to the gross value added (GVA) in 2023, followed by financial intermediation, real estate, and business activities (12.4%) and wholesale, retail, and hotels (6.1%). In nominal terms, the three sectors are forecast to grow by 4.5%, 5.3%, and 5.2%, respectively, in 2024. Three major cities in Norway generated 39.9% of the country’s GDP in 2023 and comprised 33.5% of the country’s population, as of 2023.
-
Product Insights
Premature Labor (Tocolysis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Drugs In Development, 2023’, provides an overview of the Premature Labor (Tocolysis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Irritable Bowel Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Irritable Bowel Syndrome - Drugs In Development, 2023’, provides an overview of the Irritable Bowel Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Irritable Bowel Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Generalized Anxiety Disorder (GAD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Generalized Anxiety Disorder (GAD) - Drugs In Development, 2023’, provides an overview of the Generalized Anxiety Disorder (GAD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Bacterial Vaginosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bacterial Vaginosis - Drugs In Development, 2023’, provides an overview of the Bacterial Vaginosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Urinary Tract Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Urinary Tract Infections - Drugs In Development, 2023’, provides an overview of the Urinary Tract Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Urinary Tract Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Major Depressive Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Major Depressive Disorder - Drugs In Development, 2023’, provides an overview of the Major Depressive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Major Depressive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Healthy Snacks Market Size, Share, Trends and Analysis by Region, Products and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Healthy Snacks’ report can help you: Make informed decisions about market entry, technology adoption, and project planning Identify your competitors' capabilities to stay ahead in the market Identify promising segments (products), growth trends, regional trends, and markets to expand your regional presence, product portfolio, and discover successful investment opportunities. Anticipate changes in demand and adjust your business development strategies. Identify ongoing potential projects across regions. How is our ‘Healthy Snacks’ report different from other reports in the market? The report...
-
Sector Analysis
Japan Oil Seeds Market Summary, Competitive Analysis and Forecast to 2027
Oil Seeds in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Oilseeds are predominantly cultivated for the purpose of obtaining edible oils from their seeds. Oil can be obtained from Oilseeds by employing both mechanical and solvent-based extraction methods. Oilseeds are used in...